Novartis
NVS
815 hedge funds and large institutions have $19.8B invested in Novartis in 2013 Q4 according to their latest regulatory filings, with 107 funds opening new positions, 286 increasing their positions, 285 reducing their positions, and 41 closing their positions.
161% more first-time investments, than exits
New positions opened: 107 | Existing positions closed: 41
36% more call options, than puts
Call options by funds: $182M | Put options by funds: $134M
7% more funds holding
Funds holding: 761 → 815 (+54)
6% more capital invested
Capital invested by funds: $18.7B → $19.8B (+$1.11B)
0% more repeat investments, than reductions
Existing positions increased: 286 | Existing positions reduced: 285
0.09% more ownership
Funds ownership: 9.91% → 9.99% (+0.09%)
5% less funds holding in top 10
Funds holding in top 10: 55 → 52 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EARNEST Partners
Atlanta,
Georgia
|
+$179M |
| 2 |
Boston Partners
Boston,
Massachusetts
|
+$175M |
| 3 |
TCIM
TIAA CREF Investment Management
New York
|
+$59.1M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$56.5M |
| 5 |
WCM
Wedge Capital Management
Charlotte,
North Carolina
|
+$42.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Neuberger Berman Group
New York
|
-$137M |
| 2 |
EAM
Edge Asset Management
Seattle,
Washington
|
-$72.1M |
| 3 |
BBHC
Brown Brothers Harriman & Co
New York
|
-$67.4M |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$43.1M |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$42.3M |
NVS Hedge Fund Activity: Q4 2013 in Review
815 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Novartis (NVS) for Q4 2013, worth a combined $19.8B — up 5.9% from $18.7B a quarter earlier.
Buyers outnumbered sellers: 107 funds opened new NVS positions and 41 closed out — a net gain of 66 holders — while 286 added to existing stakes and 285 trimmed.
The largest buyer was EARNEST Partners, opening a new position worth an estimated $179M. The largest seller was Neuberger Berman Group, cutting an estimated $137M.
- 815 institutional investors held Novartis (NVS) as of Q4 2013, up from 761 in Q3 2013.
- Funds reported $19.8B of Novartis stock for Q4 2013, up 5.9% quarter-over-quarter.
- 107 funds opened new Novartis positions in Q4 2013 and 41 closed out, a net change of +66 holders.
- The largest Novartis buyer in Q4 2013 was EARNEST Partners, an estimated $179M added.
- The largest Novartis seller in Q4 2013 was Neuberger Berman Group, an estimated $137M sold.
Based on aggregated 13F filings for Q4 2013.